ARS Pharmaceuticals, Inc.‘s stocks are currently a part of 45 hedge funds’ portfolios, which represents 55.92% of the total amount of its stocks outstanding. This makes up a total of 22.34M shares of ARS Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -55.43% or -27.78M shares fewer. As for the holding position changes, 40% (18) of current hedge fund investors increased the number of shares held, 20% (9) of current holders sold a part of the shares held, and 13.33% (6) closed the holdings completely. 13 hedge funds are new holders of ARS Pharmaceuticals, Inc. stock in Q1 2023, it is 28.89% of total holders.
